HF Foods Reports First Quarter 2024 Financial Results
Highest Net Revenue Ever Recorded During First Quarter of $295.7 MillionPre-Recorded Earnings Call Webcast Available on Investor Relations WebsiteRead more...
Month: May 2024
Global Mofy Metaverse Pioneers the “Next Generation” of Content Creation with Gausspeed
BEIJING, May 08, 2024 (GLOBE NEWSWIRE) -- Global Mofy Metaverse Limited (the "Company" or "Global Mofy Metaverse") (Nasdaq: GMM), a...
First Merchants Corporation Announces Cash Dividend
MUNCIE, Ind., May 08, 2024 (GLOBE NEWSWIRE) -- First Merchants Corporation declared a cash dividend on May 7, 2024 of...
Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of...
Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights
SALT LAKE CITY, May 08, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its...
Cognyte Strengthens Relationship with National Intelligence Organization, Secures Approximately $5 Million Follow-On Order
Ongoing partnership and third order underscores confidence in Cognyte solutions Contacts Investor Relations: Dean Ridlon Cognyte Software Ltd. IR@cognyte.com Media:...
SRAX Signs Agreement to Merge with DNA Holdings
Westlake Village, CA, May 08, 2024 (GLOBE NEWSWIRE) -- SRAX Inc. (OTC: SRAX), a financial technology company that unlocks data...
Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference
WATERTOWN, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing...
SIGMA LITHIUM INCREASES PROVEN & PROBABLE OPEN PIT MINERAL RESERVE BY 40% TO 77Mt EXTENDING OPERATIONS TO 25 YEARS
HIGHLIGHTS SÃO PAULO, May 8, 2024 /PRNewswire/ -- Sigma Lithium Corporation ("Sigma Lithium" or the "Company") (NASDAQ: SGML, BVMF: S2GM34, TSXV:...
IntelGenx Announces Voting Results on Election of Directors
SAINT LAURENT, Quebec, May 08, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces...
24/7 Market News Publishes Report on the Multi Club Ownership Movement Featuring Brera Holdings
DENVER, Colo., May 08, 2024- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news...
WhiteHorse Finance, Inc. Announces First Quarter 2024 Earnings Results and Declares Quarterly Distribution of $0.385 Per Share
NEW YORK, May 8, 2024 /PRNewswire/ -- WhiteHorse Finance, Inc. ("WhiteHorse Finance" or the "Company") (Nasdaq: WHF) today announced its financial...
Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
WEST CHESTER, Pa., May 08, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology...
U.S. Gold Corp. Announces Mine Operating Permit Approval for the CK Gold Project in Wyoming
Attains Major Permitting Milestone Towards the Development of the CK Gold Project CHEYENNE, Wyo., May 8, 2024 /PRNewswire/ -- U.S....
EchoStar Announces Financial Results for the Three Months Ended March 31, 2024
ENGLEWOOD, Colo., May 8, 2024 /PRNewswire/ -- EchoStar Corporation (NASDAQ: SATS) announced its financial results for the three months ended...
Payoneer Reports First Quarter 2024 Financial Results
Record quarterly revenue, up 19% year-over-year, driven by strong growth across the entire platform 21% volume growth, including 33% B2B...
MasterCraft Boat Holdings, Inc. Reports Results for Fiscal 2024 Third Quarter
VONORE, Tenn., May 08, 2024 (GLOBE NEWSWIRE) -- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its...
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing...
Kornit Digital Reports First Quarter 2024 Results
ROSH-HA`AYIN, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- Kornit Digital Ltd. (“Kornit” or the “Company”) (Nasdaq: KRNT), a worldwide market...
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
– Announces Significant Refinancing Transactions and Amends Royalty Agreement with HealthCare Royalty Extending Vast Majority of Its Debt Maturities into...
Kelly to Participate in the 18th Annual Barrington Research Virtual Spring Investment Conference
TROY, Mich., May 08, 2024 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today...
Kelly to Participate in the 18th Annual Barrington Research Virtual Spring Investment Conference
TROY, Mich., May 08, 2024 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today...
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
JENA, Germany, May 08, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today...
FitLife Brands Announces First Quarter Earnings Call and its Participation at Sidoti Virtual Investor Conference and Provides Operational Update
OMAHA, NE, May 08, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of...
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
Data Support Advancement to Phase 2 Clinical Trial in Patients with Heart Failure with Preserved Ejection Fraction Expected to Begin in...
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights
Generated Significant 37% Year-over-Year Revenue Growth in Q1 2024Recorded Positive Quarterly Net Income for Second Consecutive Quarter, and Positive Adjusted...
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
— New therapeutic candidate developed using Company’s patented ThermoStem® platform —— Candidate has potential to serve as an adjuvant to...
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
- ATH434-201 Trial on Track to Complete in November 2024 –- Top-Line Data Expected in January 2025 -MELBOURNE, Australia and...
Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market
NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company Launches Premium Products Redefining Patient Care EDMONTON, AB, May 8, 2024 /PRNewswire/...
Amerigo Announces Q1-2024 Results & Quarterly Dividend
Q1-2024 net income of $4.3 millionQuarterly EBITDA1 of $13.6 million – free cash flow to equity1 of $7.3 millionRead more...
Crescita Reports First Quarter 2024 Results
Contacts FOR MORE INFORMATION, PLEASE CONTACT: Linda Kisa, CPA, CA Vice-President, Reporting and Corporate Affairs Email: lkisa@crescitatx.com Crescita Therapeutics Inc....
SCOTTIE RESOURCES OUTLINES 2024 EXPLORATION PLAN
VANCOUVER, BC, May 8, 2024 /PRNewswire/ - Scottie Resources Corp. ("Scottie" or the "Company") (TSXV: SCOT) (OTCQB: SCTSF) (FSE: SR8) is...
WTW boosts global cyber facility with increased capacity and broader coverage options
LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, today announces...
Innoviva to Participate in the BofA Securities Health Care Conference
Contacts Innoviva, Inc. David Patti Corporate Communications (908) 421-5971 david.patti@inva.com Investors and Media: Argot Partners (212) 600-1902 innoviva@argotpartners.com Innoviva, Inc....
Gilat Reports First Quarter 2024 Results
PETAH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader...
Expensify to Launch New Travel Offering
Expensify Travel will begin rolling out to customers next week on the expense management company’s next-gen platform, New Expensify. Contacts...
Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids
Biotechnology licensee expected to progress methods targeting breast and other cancers using cannabinoids in combination with chemotherapeutic drugs Contacts Investor...
Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
CTx-1301 on track to file for Marketing Approval with FDA in 1H 2025Increase of $10 Million in Stockholders’ Equity KANSAS...
Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
CTx-1301 on track to file for Marketing Approval with FDA in 1H 2025Increase of $10 Million in Stockholders’ Equity KANSAS...